You just read:

Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A

News provided by

Transparency Market Research

Dec 08, 2016, 10:30 ET